JP2012092144A5 - - Google Patents

Download PDF

Info

Publication number
JP2012092144A5
JP2012092144A5 JP2012022511A JP2012022511A JP2012092144A5 JP 2012092144 A5 JP2012092144 A5 JP 2012092144A5 JP 2012022511 A JP2012022511 A JP 2012022511A JP 2012022511 A JP2012022511 A JP 2012022511A JP 2012092144 A5 JP2012092144 A5 JP 2012092144A5
Authority
JP
Japan
Prior art keywords
cell
test substance
psgl
cells
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012022511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012092144A (ja
Filing date
Publication date
Priority claimed from US10/051,497 external-priority patent/US7744888B2/en
Application filed filed Critical
Publication of JP2012092144A publication Critical patent/JP2012092144A/ja
Publication of JP2012092144A5 publication Critical patent/JP2012092144A5/ja
Pending legal-status Critical Current

Links

JP2012022511A 2001-08-03 2012-02-03 P−セレクチン糖タンパク質リガンド1のモジュレーター Pending JP2012092144A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31019601P 2001-08-03 2001-08-03
US60/310,196 2001-08-03
US10/051,497 2002-01-18
US10/051,497 US7744888B2 (en) 2001-08-03 2002-01-18 Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008058501A Division JP2008260759A (ja) 2001-08-03 2008-03-07 P−セレクチン糖タンパク質リガンド1のモジュレーター

Publications (2)

Publication Number Publication Date
JP2012092144A JP2012092144A (ja) 2012-05-17
JP2012092144A5 true JP2012092144A5 (enExample) 2013-06-06

Family

ID=26729479

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003518607A Expired - Fee Related JP4815101B2 (ja) 2001-08-03 2002-03-13 P−セレクチン糖タンパク質リガンド1のモジュレーター
JP2008058501A Abandoned JP2008260759A (ja) 2001-08-03 2008-03-07 P−セレクチン糖タンパク質リガンド1のモジュレーター
JP2012022511A Pending JP2012092144A (ja) 2001-08-03 2012-02-03 P−セレクチン糖タンパク質リガンド1のモジュレーター

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2003518607A Expired - Fee Related JP4815101B2 (ja) 2001-08-03 2002-03-13 P−セレクチン糖タンパク質リガンド1のモジュレーター
JP2008058501A Abandoned JP2008260759A (ja) 2001-08-03 2008-03-07 P−セレクチン糖タンパク質リガンド1のモジュレーター

Country Status (19)

Country Link
US (3) US7744888B2 (enExample)
EP (2) EP1411982B1 (enExample)
JP (3) JP4815101B2 (enExample)
KR (1) KR100850731B1 (enExample)
CN (2) CN101045161B (enExample)
AT (2) ATE411045T1 (enExample)
AU (1) AU2002305041B2 (enExample)
CA (1) CA2428822C (enExample)
CY (2) CY1108701T1 (enExample)
DE (1) DE60229394D1 (enExample)
DK (2) DK1411982T3 (enExample)
ES (2) ES2316569T3 (enExample)
IL (4) IL160168A0 (enExample)
MX (1) MXPA04001047A (enExample)
NO (2) NO333456B1 (enExample)
NZ (1) NZ531199A (enExample)
PT (2) PT1985634E (enExample)
TW (1) TWI327070B (enExample)
WO (1) WO2003013603A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116333A1 (en) 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
AU2004273807B2 (en) * 2003-09-15 2011-06-09 Abgenomics Cooperatief U.A. Modulators of P-Selectin Glycoprotein Ligand 1
US7459523B2 (en) * 2003-11-12 2008-12-02 Wisconsin Alumni Research Foundation Equine P-selectin glycoprotein ligand-1 and uses thereof
UY28886A1 (es) * 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
AU2012201999C1 (en) * 2004-05-10 2016-05-12 Abgenomics Cooperatief U.A. Antibodies
BRPI0510561A (pt) * 2004-05-11 2007-11-20 Abgenomics Corp epìtopos que induzem morte de célula t
WO2007033959A2 (en) * 2005-09-19 2007-03-29 Vib Vzw Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas
US20070160601A1 (en) * 2005-12-09 2007-07-12 Angela Widom Neutralizing antibodies against primate psgl-1 and uses therefor
AU2009246166B2 (en) * 2008-05-15 2014-09-18 Tetherex Pharmaceuticals Corporation Anti-PSGL-1 antibodies and methods of identification and use
ES2387156B1 (es) * 2010-12-01 2013-07-04 Universidad Autónoma de Madrid Uso de psgl-1 para el tratamiento de enfermedades inflamatorias y autoinmunes
CN116063522A (zh) 2011-06-13 2023-05-05 美国全心医药生技股份有限公司 抗psgl-1抗体及其用途
EP3881863A1 (en) * 2014-07-08 2021-09-22 Sanford-Burnham Medical Research Institute Psgl-1 modulators and uses thereof
ES2880731T3 (es) 2016-01-08 2021-11-25 Altrubio Inc Anticuerpos anti-PSGL-1 tetravalentes y usos de los mismos
US20170241415A1 (en) * 2016-02-19 2017-08-24 Muzan, Inc. Sanitary check valve
JP7244422B2 (ja) 2017-01-11 2023-03-22 ブリストル-マイヤーズ スクイブ カンパニー Psgl-1アンタゴニスト及びその使用
SG11201907848YA (en) 2017-03-14 2019-09-27 Five Prime Therapeutics Inc Antibodies binding to vista at acidic ph
MX2020009786A (es) 2018-03-21 2020-10-12 Five Prime Therapeutics Inc Anticuerpos de union a supresor de la activacion de celulas t que contiene el dominio variable de inmunoglobulina (vista) a ph acido.
US12091462B2 (en) 2018-07-11 2024-09-17 Five Prime Therapeutics, Inc. Antibodies binding to vista at acidic pH
CN118994395A (zh) 2018-07-20 2024-11-22 皮埃尔法布雷医药公司 Vista受体
WO2020224450A1 (en) * 2019-05-03 2020-11-12 The University Of Hong Kong Method for peritoneal metastatic cell detection and isolation thereof
TW202110891A (zh) * 2019-06-04 2021-03-16 美商維西歐製藥公司 抗psgl-1組合物及其用於調節骨髓細胞發炎表型之方法及用途
WO2025168211A1 (en) * 2023-02-10 2025-08-14 Novo Nordisk A/S P-selectin peptide ligands

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5378464A (en) 1989-03-08 1995-01-03 Board Of Regents Of The University Of Oklahoma Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140
US5464778A (en) 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5690933A (en) * 1989-05-31 1997-11-25 Glaxo Wellcome Inc. Monoclonal antibodies for inducing tolerance
KR100272077B1 (ko) 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5709859A (en) 1991-01-24 1998-01-20 Bristol-Myers Squibb Company Mixed specificity fusion proteins
US6309639B1 (en) 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US6124267A (en) 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US5972625A (en) 1991-05-06 1999-10-26 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5843707A (en) 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
WO1994014836A1 (en) 1992-12-18 1994-07-07 Centocor, Inc. Peptide inhibitors of selectin binding
ES2126742T3 (es) 1993-01-25 1999-04-01 Dana Farber Cancer Inst Inc Selectinas quimericas obtenidas mediante intercambio de dominios - sus usos.
WO1995014787A1 (en) 1993-11-22 1995-06-01 Centocor, Inc. Peptide inhibitors of selecting binding
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
ES2208759T3 (es) 1995-08-03 2004-06-16 Board Of Regents Of The University Of Oklahoma O-glicanos inhibidores de la inflamacion mediada por selectina.
JPH09227410A (ja) 1996-02-21 1997-09-02 Sumitomo Pharmaceut Co Ltd 臓器移植拒絶反応の抑制剤
WO1999043353A2 (en) 1998-02-26 1999-09-02 Boehringer Ingelheim Pharmaceuticals, Inc. Combination anti-selectin and immunosuppressant therapy
NZ528610A (en) 1998-10-30 2005-03-24 Inst Genetics Llc Inhibition of differentiation of cytotoxic T-cells by P-selectin ligand (PSGL) antagonists
US20040001839A1 (en) 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
JP2005503756A (ja) 2000-12-29 2005-02-10 サビエント ファーマシューティカルズ,インコーポレイティド 硫酸化部分を含むエピトープを含む単離分子、当該エピトープに対する抗体、及びその使用
US20040116333A1 (en) 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US20050152906A1 (en) * 2003-06-30 2005-07-14 Avigdor Levanon Specific human antibodies
UY28886A1 (es) 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
BRPI0510561A (pt) 2004-05-11 2007-11-20 Abgenomics Corp epìtopos que induzem morte de célula t
CN116063522A (zh) 2011-06-13 2023-05-05 美国全心医药生技股份有限公司 抗psgl-1抗体及其用途

Similar Documents

Publication Publication Date Title
JP2012092144A5 (enExample)
NZ711723A (en) Microfluidic devices and methods for use thereof in multicellular assays of secretion
MX2017005750A (es) Ensayos para detectar subgrupos inmunes de células t y sus métodos de uso.
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
WO2014015194A3 (en) Methods for detecting and measuring aggregation
WO2015153018A3 (en) Immunoassay utilizing trapping conjugate
EP2801092A4 (en) METHODS, DEVICES AND COMPUTER PROGRAM PRODUCTS FOR IMPLEMENTING AUTOMATIC LANGUAGE RECOGNITION AND RECEIVING RECOGNITION ON A DEVICE
AR090549A1 (es) Anticuerpos anti-lgr5 e inmunoconjugados
GB201108236D0 (en) Method
MX392706B (es) Ensayo a base de células para detectar homodímeros anti-cd3.
JP2016511405A5 (enExample)
EP2972348A4 (en) METHOD FOR DETECTING DONATOR-SPECIFIC ANTIBODIES AND SYSTEMS FOR CARRYING OUT THEREOF
MX2014003984A (es) Metodo para detectar anticuerpos a-beta especificos en una muestra biologica.
PH12016501339A1 (en) Novel anti-netrin-1 antibody
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
EP2710408A4 (en) SEISMIC DEVICE WITH SEALED HOUSING AND ASSOCIATED METHODS
JP2015520378A5 (enExample)
SG10201806729VA (en) Novel assay to detect human periostin
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
WO2016077558A8 (en) Methods for blood typing and antibody screening
EP2546266A4 (en) MONOCLONAL ANTIBODY AGAINST THE NEKROSEMARKER ERP29 AND USE THEREOF
SG11201700407QA (en) Frame member-equipped transfer film, biomolecule analysis device, reagent tank, and shaking device
SG10201806428YA (en) Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
FR2996010B1 (fr) Dispositif de prediction des seismes et des eruptions volcaniques, de localisation des epicentres et des magnitudes par la mesure du radon dans le sol
WO2017035315A8 (en) Methods and device for phenotypic classification of cells based on migratory behavior